NeuroSense Therapeutics, Ltd. - NRSN Sotuvning operatsion marjasi

NeuroSense Therapeutics Ltd (NRSN) kompaniyasining korporativ logotipi

Harorat nazorati bilan biomateriallarning murakkab tashilishi klinik sinovlar uchun xavflarni keltirib chiqaradi, bu esa NeuroSense Therapeutics (NRSN) kompaniyasining operatsion daromadli tendentsiyasini ko'rsatadi. 0.00 belgisi joriy samaradorlik darajasini anglatadi. Rivojlanish bosqichi tufayli barqaror pul oqimi mavjud emas; biroq, kelajakdagi molekulalarning sertifikatsiyasi BAS dori vositalarining global taqsimoti davomida arzon autsorsing orqali yuqori marjalarni ta'minlaydi.

NRSN: NeuroSense Therapeutics Ltd Operatsion foyda normasi 04.07.2022 - 19.11.2026

NeuroSense Therapeutics Ltd - tahliliy kesimlar va asosiy koʻrsatkichlar (NRSN)

- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning asosiy tahlili:NRSN, neurosense-tx.com
NeuroSense Therapeutics Ltd. asosiy tovari

Investorlar aktivlarning operatsion kuchini EBIT dagi asosiy operatsion foyda ulushi orqali baholaydilar, ushbu tendentsiya operatsion foyda marjasining dinamikasi bilan aniq ifodalanadi. Ishlab chiqarishni CDMO zavodlariga topshirgan NeuroSense Therapeutics (NRSN) uchun ushbu ko'rsatkich ishlab chiqarish liniyalariga egalik qilmagan holda xarajatlarni boshqarish samaradorligini tasdiqlaydi va biznes modelining umumiy barqarorligini belgilaydi.

NeuroSense Therapeutics kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi BIIB|NBIX: Operatsion foyda normasi|Operatsion rentabellik Regencell Bioscience Ltd (RGC)|Operatsion marja axsome.com (AXSM)|Operatsion marja ACAD (acadia-pharm.com)|XENE - Sotuvning operatsion marjasi|vikingtherapeutics.com - Operatsion marja|Supernus Pharma (SUPN) - Sotuvning operatsion marjasi|CPRX: Operatsion marja|Denali Therapeutics Inc. (DNLI) - Operatsion marja|Operatsion rentabellik Harmony Pharma|Operatsion rentabellik BHVN|Sotuvning operatsion marjasi AMLX (Amylyx Pharmaceuticals, Inc.)|Sotuvning operatsion marjasi Trevi Corp TRVI|Operatsion rentabellik praxismedicines.com PRAX|AVXL - Sotuvning operatsion marjasi|CeriBell EEG - Operatsion marja|Sotuvning operatsion rentabelligi prothena.com|Alector Therapeutics (ALEC) - Operatsion rentabellik|Annexon Biosciences Inc. - Operatsion foyda normasi|OMER (Omeros Corp) - Operatsion marja|Operatsion marja neurogene.com|Operatsion marja ACIU|VYGR - Sotuvning operatsion rentabelligi|Operatsion rentabellik Neumora Therapeutics Inc NMRA|Operatsion faoliyat rentabelligi Scilex Holding Co. (SCLX)|TVGN - Operatsion rentabellik|Sotuvning operatsion rentabelligi alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Sotuvning operatsion marjasi|IKT: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Cassava Sciences, Inc.|ASRT (assertiotx.com) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Coya (COYA)|VTGN - Sotuvning operatsion rentabelligi|Operatsion marja OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Sotuvning operatsion rentabelligi|cervomed.com - Operatsion marja|Operatsion foyda normasi ATHE (Alterity Therapeutics Limited)|CLNN: Operatsion marja|Sotuvning operatsion marjasi PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Relmada Therapeutics Inc RLMD|Operatsion rentabellik Annovis Bio Corporation (ANVS)|GRCE - Sotuvning operatsion rentabelligi|Operatsion rentabellik Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Sotuvning operatsion rentabelligi|RVPH: Sotuvning operatsion marjasi|MTVA: Operatsion rentabellik|NRXS (NeurAxis Inc) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Helius Medical Technologies, Inc.|Operatsion rentabellik Passage Bio Inc.|Sotuvning operatsion rentabelligi bionomics.com.au NEUP|Operatsion marja NERV|Operatsion marja Athira Pharma Inc (ATHA)|Operatsion marja ADXN (Addex Therapeutics Ltd.)|ALZN: Operatsion foyda bo'yicha sotuv rentabelligi|CYCN - Operatsion rentabellik|Sotuvning operatsion rentabelligi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha marjinallik Cortigent, Inc. CRGT|Operatsion rentabellik Avenue Therapeutics, Inc.|Sotuvning operatsion marjasi BrainStorm Cell Therapeutics Inc. (BCLI)|Operatsion rentabellik Cara Therapeutics, Inc (CARA)|Operatsion rentabellik CHRO (Chromocell Therapeutics Corp.)|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi